{"id":1928,"date":"2024-10-09T11:32:52","date_gmt":"2024-10-09T10:32:52","guid":{"rendered":"https:\/\/dev.oximio.com\/?post_type=oximio-resources&#038;p=1928"},"modified":"2024-10-18T06:05:01","modified_gmt":"2024-10-18T05:05:01","slug":"oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication","status":"publish","type":"oximio-resources","link":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/","title":{"rendered":"Oximio Israel excels in securing import licenses for unlicensed medication"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1928\" class=\"elementor elementor-1928\">\n\t\t\t\t<section class=\"elementor-element elementor-element-3e5ce9fa e-con-full e-flex e-con e-parent\" data-id=\"3e5ce9fa\" data-element_type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-6bb1d0e4 e-flex e-con-boxed e-con e-child\" data-id=\"6bb1d0e4\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-52b30e9c elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"52b30e9c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"et_pb_row et_pb_row_0\"><div class=\"et_pb_column et_pb_column_1_2 et_pb_column_0  et_pb_css_mix_blend_mode_passthrough\"><div class=\"et_pb_module et_pb_text et_pb_text_0  et_pb_text_align_left et_pb_bg_layout_light\"><div class=\"et_pb_text_inner\"><h5>We are delighted to announce that Oximio Israel has been successfully awarded yet another import license for\u00a0<strong>Compassionate use program<\/strong>\u00a0in January 2023.<br \/><br \/><\/h5><p>\u201cCompassionate use\u201d allows for a patient outside of clinical trials with a serious or life-threatening disease to gain access to an investigational medical product including drug, biologic, or medical device when no alternative therapy options are available.<\/p><\/div><\/div><\/div><div class=\"et_pb_column et_pb_column_1_2 et_pb_column_1  et_pb_css_mix_blend_mode_passthrough et-last-child\"><div class=\"et_pb_module et_pb_image et_pb_image_0\">\u00a0<\/div><\/div><\/div><div class=\"et_pb_row et_pb_row_1\"><div class=\"et_pb_column et_pb_column_4_4 et_pb_column_2  et_pb_css_mix_blend_mode_passthrough et-last-child\"><div class=\"et_pb_module et_pb_text et_pb_text_1  et_pb_text_align_left et_pb_bg_layout_light\"><div class=\"et_pb_text_inner\"><p><strong>There are three scenarios when a patient can get an access to the unlicensed medication:<br \/><br \/><\/strong><\/p><ol><li><strong>Compassionate use program<\/strong>: the patient has never taken part in a clinical trial.<br \/><br \/><\/li><li><strong>Post-trial access<\/strong>: the patient has completed or dropped out of the clinical trial.<br \/><br \/><\/li><li><strong>Unlicensed supply<\/strong>: when the unregistered medication can be imported for an individual patient.<\/li><\/ol><p><br \/>Oximio Israel has been successfully arranging licences for the above programmes since 2014.<\/p><p>At Oximio we strive to put the patient first and to find solutions to better our patient-centric services to compassionately achieve the best experience and outcome for the person and the family.<\/p><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"featured_media":1929,"template":"","meta":{"_acf_changed":false},"resources-categories":[10],"class_list":["post-1928","oximio-resources","type-oximio-resources","status-publish","has-post-thumbnail","hentry","resources-categories-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oximio Israel excels in securing import licenses for unlicensed medication<\/title>\n<meta name=\"description\" content=\"Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oximio.com\/tr\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oximio Israel excels in securing import licenses for unlicensed medication\" \/>\n<meta property=\"og:description\" content=\"Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/\" \/>\n<meta property=\"og:site_name\" content=\"Oximio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Oximio\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-18T05:05:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oximio.com\/wp-content\/uploads\/2024\/10\/compassionate-use-medication.png\" \/>\n\t<meta property=\"og:image:width\" content=\"940\" \/>\n\t<meta property=\"og:image:height\" content=\"788\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/\",\"url\":\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/\",\"name\":\"Oximio Israel excels in securing import licenses for unlicensed medication\",\"isPartOf\":{\"@id\":\"https:\/\/oximio.com\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oximio.com\/wp-content\/uploads\/2024\/10\/compassionate-use-medication.png\",\"datePublished\":\"2024-10-09T10:32:52+00:00\",\"dateModified\":\"2024-10-18T05:05:01+00:00\",\"description\":\"Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023\",\"breadcrumb\":{\"@id\":\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#primaryimage\",\"url\":\"https:\/\/oximio.com\/wp-content\/uploads\/2024\/10\/compassionate-use-medication.png\",\"contentUrl\":\"https:\/\/oximio.com\/wp-content\/uploads\/2024\/10\/compassionate-use-medication.png\",\"width\":940,\"height\":788,\"caption\":\"Compassionate use unlicenced medication approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/oximio.com\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oximio Israel excels in securing import licenses for unlicensed medication\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oximio.com\/tr\/#website\",\"url\":\"https:\/\/oximio.com\/tr\/\",\"name\":\"Oximio\",\"description\":\"We deliver care\",\"publisher\":{\"@id\":\"https:\/\/oximio.com\/tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oximio.com\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oximio.com\/tr\/#organization\",\"name\":\"Oximio\",\"url\":\"https:\/\/oximio.com\/tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/oximio.com\/tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oximio.com\/wp-content\/uploads\/2024\/09\/Oximio_logo-01.jpg\",\"contentUrl\":\"https:\/\/oximio.com\/wp-content\/uploads\/2024\/09\/Oximio_logo-01.jpg\",\"width\":2501,\"height\":1363,\"caption\":\"Oximio\"},\"image\":{\"@id\":\"https:\/\/oximio.com\/tr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Oximio\/\",\"https:\/\/www.linkedin.com\/company\/smo-group\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oximio Israel excels in securing import licenses for unlicensed medication","description":"Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oximio.com\/tr\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/","og_locale":"tr_TR","og_type":"article","og_title":"Oximio Israel excels in securing import licenses for unlicensed medication","og_description":"Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023","og_url":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/","og_site_name":"Oximio","article_publisher":"https:\/\/www.facebook.com\/Oximio\/","article_modified_time":"2024-10-18T05:05:01+00:00","og_image":[{"width":940,"height":788,"url":"https:\/\/oximio.com\/wp-content\/uploads\/2024\/10\/compassionate-use-medication.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/","url":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/","name":"Oximio Israel excels in securing import licenses for unlicensed medication","isPartOf":{"@id":"https:\/\/oximio.com\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#primaryimage"},"image":{"@id":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#primaryimage"},"thumbnailUrl":"https:\/\/oximio.com\/wp-content\/uploads\/2024\/10\/compassionate-use-medication.png","datePublished":"2024-10-09T10:32:52+00:00","dateModified":"2024-10-18T05:05:01+00:00","description":"Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023","breadcrumb":{"@id":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#primaryimage","url":"https:\/\/oximio.com\/wp-content\/uploads\/2024\/10\/compassionate-use-medication.png","contentUrl":"https:\/\/oximio.com\/wp-content\/uploads\/2024\/10\/compassionate-use-medication.png","width":940,"height":788,"caption":"Compassionate use unlicenced medication approval"},{"@type":"BreadcrumbList","@id":"https:\/\/oximio.com\/resources\/oximio-israel-excels-in-securing-import-licenses-for-unlicensed-medication\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/oximio.com\/tr\/"},{"@type":"ListItem","position":2,"name":"Oximio Israel excels in securing import licenses for unlicensed medication"}]},{"@type":"WebSite","@id":"https:\/\/oximio.com\/tr\/#website","url":"https:\/\/oximio.com\/tr\/","name":"Oximio","description":"We deliver care","publisher":{"@id":"https:\/\/oximio.com\/tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oximio.com\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/oximio.com\/tr\/#organization","name":"Oximio","url":"https:\/\/oximio.com\/tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/oximio.com\/tr\/#\/schema\/logo\/image\/","url":"https:\/\/oximio.com\/wp-content\/uploads\/2024\/09\/Oximio_logo-01.jpg","contentUrl":"https:\/\/oximio.com\/wp-content\/uploads\/2024\/09\/Oximio_logo-01.jpg","width":2501,"height":1363,"caption":"Oximio"},"image":{"@id":"https:\/\/oximio.com\/tr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Oximio\/","https:\/\/www.linkedin.com\/company\/smo-group"]}]}},"_links":{"self":[{"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/oximio-resources\/1928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/oximio-resources"}],"about":[{"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/types\/oximio-resources"}],"version-history":[{"count":5,"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/oximio-resources\/1928\/revisions"}],"predecessor-version":[{"id":1934,"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/oximio-resources\/1928\/revisions\/1934"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/media\/1929"}],"wp:attachment":[{"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/media?parent=1928"}],"wp:term":[{"taxonomy":"resources-categories","embeddable":true,"href":"https:\/\/oximio.com\/tr\/wp-json\/wp\/v2\/resources-categories?post=1928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}